Stoneridge (SRI) Q3 2026 Earnings Call Transcript

Stoneridge reported Q3 adjusted revenue of $180.0 million, up 29.9% year over year, and adjusted EBITDA of $7.3 million, up 41.7%; organic revenue growth was 26%, its fastest pace in more than three years. The company raised FY2026 revenue guidance to $690 million–$700 million from $645 million–$670 million, but expects adjusted EBITDA of $20 million–$25 million at the bottom end amid inflation and currency headwinds. Results also include a $25.5 million arbitration award tied to a former Control Devices business product; Stoneridge disputes the ruling and says it can pay from cash on hand. Debt was $143.7 million and classified as a current liability ahead of the July 2027 credit-facility maturity, with refinancing underway.

Analysis

The key underwriting issue is conversion, not demand: higher volumes are producing only modest EBITDA margin expansion while memory inflation, warranty actions and mix weigh on gross margin. If cost recovery lags, incremental sales may add little earnings or cash despite strong reported growth. The $180 million of expected sales through 2028 is cumulative, tied to an undisclosed program, and not evidence of equivalent profit contribution; treat it as a backlog signal, not a near-term earnings reset. Inventory built ahead of 2027 launches raises the downside if OEM timing slips or quality issues recur.

The more immediate balance-sheet catalyst is refinancing. Classifying borrowings as current reflects the July 2027 maturity, not an imminent payment, but completion terms matter: weaker pricing or tighter covenants could absorb the benefit of operating improvement. The arbitration award is also meaningful against cash reserves, even if management says it can be paid from cash on hand. Track cash conversion after settlement, inventory turns and refinancing progress.

MirrorEye’s North American ramp and broader vision-system wins could improve utilization and strengthen Stoneridge’s position with OEMs over 6–18 months, but adoption and margin economics remain unproven. Kodiak AI collaboration is exploratory platform optionality; no disclosed economics support valuing it as material revenue today. Consensus may over-credit the growth headline and underweight the mismatch between raised revenue guidance and EBITDA constrained to the low end of its range.

Key Decisions for Investors

• SRI: Avoid chasing the revenue-guidance raise. Consider only a small, staged long after evidence that Q4 gross margin stabilizes and customer cost recovery offsets memory inflation; add on a completed refinancing with acceptable terms. Thesis is weakened by another margin decline, deteriorating inventory turns, or delayed refinancing.
• Treat the $180 million program and Kodiak AI tie-up as watch items, not incremental earnings estimates. Verify program timing, customer concentration, production volumes and product-level margins before underwriting a multiple re-rating; Kodiak AI has no actionable standalone signal from this announcement.
• Over the next 1–3 months, monitor refinancing disclosures, post-award cash levels and 2027 OEM schedules. If refinancing terms materially tighten or launch timing slips while inventory remains elevated, reassess SRI exposure; if cash conversion and margin recovery improve, the balance-sheet discount may ease.